Editorial Information

Trinseo Offers Medical Grade MAGNUM™ ABS for Medical Equipment

Resins provide mass polymerization advantages; meet requirements for chemical resistance, sterilization and ease of coloring

BERWYN, Pa. - Monday, April 10, 2017

Trinseo (NYSE: TSE), the global materials company and manufacturer of plastics, latex binders and synthetic rubber, is offering medical equipment manufacturers and molders medical-grade MAGNUM™ ABS Resins. The material features the advantages of Trinseo’s mass polymerization technology combined with the properties needed most for medical applications to assure the integrity of end-use applications.

Trinseo’s MAGNUM™ 8391 MED ABS Resins, are part of the company’s line of performance plastics tailored for medical device applications. Trinseo’s proprietary polymerization process results in a material that is highly consistent from lot-to-lot in terms of color, rheology and physical properties. The process results in brilliant whiteness of the material for ease of coloring and less pigment use, and results in lower residual monomers and oligomers.

Medical-industry requirements found in MAGNUM™ 8391 MED include biocompatibility, chemical resistance, sterilization options, and comprehensive regulatory support. The material also offers an extended notification of change as well as the versatility of secondary operations common in medical equipment, such as spraying, plating, solvent bonding and ultrasonic welding.

To ensure the quality required for medical applications, Trinseo adheres to strict production guidelines. Our medical manufacturing facilities and related global departments are ISO 13485:2016 certified, which places a special emphasis on risk management and process validation.

Trinseo has a history of providing the medical device industry with materials for single- and multiple-use devices and equipment housings. As a manufacturer focused on resin quality and product stewardship, Trinseo is committed to supporting the medical equipment industry with superior product quality, outstanding consistency, and the assurance of global supply.  

About Trinseo

Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.0 billion in net sales in 2020, with 17 manufacturing sites around the world, and approximately 2,600 employees. For more information, please visit: www.trinseo.com.

Cautionary Note on Forward-Looking Statements

This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding the timing of the proposed acquisition of the Arkema MMA and PMMA business (the "Acquisition"); estimated and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities and cost synergies relating to the Acquisition, our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause such a difference include, but are not limited to, our failure to complete the Acquisition or meet the conditions to closing, including antitrust, works council and other regulatory approvals; the failure to obtain the financing necessary to fund the Acquisition and the impact of the substantial indebtedness to be incurred; costs related to the Acquisition; following the Acquisition, our ability to successfully integrate the acquired businesses, generate expected cost savings and synergies, maintain relationships with customers, retain key employees and profitably grow the business; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Editorial Information

Get Exclusive Trinseo Content

Be the first to hear about new product information, company news, and more Trinseo updates conveniently via email!